✦ LIBER ✦

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial

✍ Scribed by Per Soelberg Sorensen; Svein Ivar Mellgren; Anders Svenningsson; Irina Elovaara; Jette Lautrup Frederiksen; Antonie Giaever Beiske; Kjell-Morten Myhr; Lise Vejby Søgaard; Inge Christoffer Olsen; Magnhild Sandberg-Wollheim

Book ID: 114409194
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 175 KB
Volume: 8
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(09)70085-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simvastatin as add-on therapy to interfe

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

✍ Per Soelberg Sorensen; Jan Lycke; Juha-Pekka Erälinna; Astrid Edland; Xingchen W 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 349 KB

Methylprednisolone in combination with i

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

✍ Mads Ravnborg; Per Soelberg Sørensen; Magnus Andersson; Elisabeth G Celius; Pete 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 374 KB

Alemtuzumab versus interferon beta 1a as

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

✍ Jeffrey A Cohen; Alasdair J Coles; Douglas L Arnold; Christian Confavreux; Edwar 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 334 KB

Efficacy of vitamin D3 as add-on therapy

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

✍ Joost Smolders; Raymond Hupperts; Frederik Barkhof; Luigi M.E. Grimaldi; Trygve 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 355 KB

A randomised, double blind, placebo cont

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon -1b in patients with multiple sclerosis

✍ Soilu-Hanninen, M.; Aivo, J.; Lindstrom, B.-M.; Elovaara, I.; Sumelahti, M.-L.; 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 153 KB

A randomised, double blind, placebo cont

A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

✍ Soilu-Hänninen, Merja (author);Åivo, Julia (author);Lindström, Britt Marie (auth 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 153 KB